(Q40143786)

English

Combination therapy of poly (ADP-ribose) polymerase inhibitor 3-aminobenzamide and gemcitabine shows strong antitumor activity in pancreatic cancer cells

scientific article published on May 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Combination therapy of poly (ADP-ribose) polymerase inhibitor 3-aminobenzamide and gemcitabine shows strong antitumor activity in pancreatic cancer cells (English)

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

pancreatic cancer

1 reference

based on heuristic

inferred from title

2

object named as

Marcus Bahra

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

author name string

Dietmar A Jacob

1

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Jan M Langrehr

3

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Sabine Boas-Knoop

4

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Robert Stefaniak

5

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

John Davis

6

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Guido Schumacher

7

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Steffen Lippert

8

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Ulf P Neumann

9

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

publication date

1 May 2007

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Journal of Gastroenterology and Hepatology

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

22

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

738-748

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Role of Gemcitabine in the Treatment of Advanced and Metastatic Breast Cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04496.X

21 January 2018

Gemcitabine-based combination treatment of pancreatic cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04496.X

21 January 2018

A double-blind placebo-controlled, randomised study comparing gemcitabine and marimastat with gemcitabine and placebo as first line therapy in patients with advanced pancreatic cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04496.X

21 January 2018

Chemotherapy improves survival and quality of life in advanced pancreatic and biliary cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04496.X

21 January 2018

Pancreatic carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04496.X

21 January 2018

Poly(ADP-ribose) polymerase-1 cleavage during apoptosis: an update

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04496.X

21 January 2018

The role of poly (adenosine 5'-diphosphate-ribose) polymerase in the response of pituitary tumor cells to reactive oxygen species

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04496.X

21 January 2018

5-Aminoisoquinolinone reduces renal injury and dysfunction caused by experimental ischemia/reperfusion

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04496.X

21 January 2018

Potential clinical applications of poly(ADP-ribose) polymerase (PARP) inhibitors.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04496.X

21 January 2018

The therapeutic potential of poly(ADP-ribose) polymerase inhibitors

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04496.X

21 January 2018

Suppressing orthotopic pancreatic tumor growth with a fiber-modified adenovector expressing the TRAIL gene from the human telomerase reverse transcriptase promoter

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04496.X

21 January 2018

The world according to PARP.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04496.X

21 January 2018

5-aminoisoquinolinone, a potent inhibitor of poly (adenosine 5'-diphosphate ribose) polymerase, reduces myocardial infarct size

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04496.X

21 January 2018

Beneficial effects of 5-aminoisoquinolinone, a novel, potent, water-soluble, inhibitor of poly (ADP-ribose) polymerase, in a rat model of splanchnic artery occlusion and reperfusion.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04496.X

21 January 2018

5-Aminoisoquinolinone reduces colon injury by experimental colitis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04496.X

21 January 2018

5-Aminoisoquinolinone, a novel inhibitor of poly(adenosine disphosphate-ribose) polymerase, reduces microvascular liver injury but not mortality rate after hepatic ischemia-reperfusion

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04496.X

21 January 2018

Effects of 5-aminoisoquinolinone, a water-soluble, potent inhibitor of the activity of poly (ADP-ribose) polymerase, in a rodent model of lung injury

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04496.X

21 January 2018

Pharmacological inhibition of DNA repair enzymes differentially modulates telomerase activity and apoptosis in two human leukaemia cell lines

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04496.X

21 January 2018

Suppression of pancreatic tumor growth in the liver by systemic administration of the TRAIL gene driven by the hTERT promoter

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04496.X

21 January 2018

Rapamycin-induced endothelial cell death and tumor vessel thrombosis potentiate cytotoxic therapy against pancreatic cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04496.X

21 January 2018

Differentiative pathway activated by 3-aminobenzamide, an inhibitor of PARP, in human osteosarcoma MG-63 cells.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04496.X

21 January 2018

Effects of 5-aminoisoquinolinone, a water-soluble, potent inhibitor of the activity of poly (ADP-ribose) polymerase on the organ injury and dysfunction caused by haemorrhagic shock

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04496.X

21 January 2018

Identifiers

10.1111/J.1440-1746.2006.04496.X

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40143786&oldid=1886791287"